{"title":"Comprehensive review of morphological diagnosis of adult T-cell leukemia-lymphoma.","authors":"Shigeo Fuji, Masakazu Muta, Tomoko Hisakata, Noriaki Kawano, Eiichirou Ikeda, Hiroyoshi Kouno, Yuuya Tanabe, Kayoko Nakanish","doi":"10.1080/17474086.2025.2490759","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Adult T-cell leukemia-lymphoma (ATL) is a rare hematological malignancy associated with human T-cell leukemia virus type 1 (HTLV-1) infection. Accurate diagnosis and classification of ATL clinical subtypes rely on the identification of abnormal lymphocytes in peripheral blood smears. However, the diverse morphology of ATL cells and lack of standardized evaluation criteria worldwide can pose challenges.</p><p><strong>Area covered: </strong>This review consolidates expert opinions from clinical laboratory technologists experienced in the diagnosis of ATL. Here, we present the characteristic features of ATL cells and the common pitfalls encountered in clinical practice. In acute-type ATL, the 'flower cell' with its deeply lobulated, petal-like nucleus is a hallmark feature. While highly diagnostic, flower cells may not be abundant in all samples, and cells with minimal nuclear atypia can coexist. Chronic-type ATL is often characterized by small ATL cells with nuclear indentations or twists and hyperchromatic chromatin. Smoldering-type ATL cells share a similar morphology but generally exhibit milder nuclear atypia.</p><p><strong>Expert opinion: </strong>This review would facilitate the identification of ATL cells in routine clinical practice and serves as a foundation for future discussion and standardization of morphological criteria for ATL diagnosis.</p>","PeriodicalId":12325,"journal":{"name":"Expert Review of Hematology","volume":" ","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2025-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Hematology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/17474086.2025.2490759","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Adult T-cell leukemia-lymphoma (ATL) is a rare hematological malignancy associated with human T-cell leukemia virus type 1 (HTLV-1) infection. Accurate diagnosis and classification of ATL clinical subtypes rely on the identification of abnormal lymphocytes in peripheral blood smears. However, the diverse morphology of ATL cells and lack of standardized evaluation criteria worldwide can pose challenges.
Area covered: This review consolidates expert opinions from clinical laboratory technologists experienced in the diagnosis of ATL. Here, we present the characteristic features of ATL cells and the common pitfalls encountered in clinical practice. In acute-type ATL, the 'flower cell' with its deeply lobulated, petal-like nucleus is a hallmark feature. While highly diagnostic, flower cells may not be abundant in all samples, and cells with minimal nuclear atypia can coexist. Chronic-type ATL is often characterized by small ATL cells with nuclear indentations or twists and hyperchromatic chromatin. Smoldering-type ATL cells share a similar morphology but generally exhibit milder nuclear atypia.
Expert opinion: This review would facilitate the identification of ATL cells in routine clinical practice and serves as a foundation for future discussion and standardization of morphological criteria for ATL diagnosis.
期刊介绍:
Advanced molecular research techniques have transformed hematology in recent years. With improved understanding of hematologic diseases, we now have the opportunity to research and evaluate new biological therapies, new drugs and drug combinations, new treatment schedules and novel approaches including stem cell transplantation. We can also expect proteomics, molecular genetics and biomarker research to facilitate new diagnostic approaches and the identification of appropriate therapies. Further advances in our knowledge regarding the formation and function of blood cells and blood-forming tissues should ensue, and it will be a major challenge for hematologists to adopt these new paradigms and develop integrated strategies to define the best possible patient care. Expert Review of Hematology (1747-4086) puts these advances in context and explores how they will translate directly into clinical practice.